Retatrutide (LY3437943): The Pharmacology of a Triple Receptor Agonist
Retatrutide was designed to activate three related peptide-hormone receptors — GIP, GLP-1 and glucagon. Its discovery paper describes how this single-molecule profile was characterised.
Read article